Luvixasertib hydrochloride | MedChemExpress (MCE)
CFI-402257 hydrochloride is a highly selective and orally bioavailable TTK/Mps1 inhibitor with an IC50 of 1.7 nM for TTK in vitro. CFI-402257 hydrochloride has anti-cancer activity[1].
| Trivial name | Luvixasertib hydrochloride |
| Catalog Number | HY-101340A |
| Alternative Name(s) | CFI-402257 hydrochloride |
| Research Area | Cancer |
| CAS# | 1610677-37-6 |
| Purity | 99.5% |
| SMILES | CC1=CC(C2=C3N=C(OC4=CN=CC=C4)C=C(NC[C@@H]5C[C@@](O)(C)C5)N3N=C2)=CC=C1C(NC6CC6)=O.Cl |
| Size | 100 mg |
| Supplier Page | https://www.medchemexpress.com/cfi-402257-hydrochloride.html |